Pharmacokinetic Interaction of Captopril Combination With Decoction of Soursop Leaves (Annona Muricata L.) In Male White Rats (Rattus Norvegicus) Wistar Strain
Abstract
Hypertension is a disease that cannot be cured, but can only be controlled, therefore hypertensive patients must get the treatment for the rest of their life. Currently, the treatment pattern of the community has started to return to using natural ingredients as a therapeutic alternative. The community considers the use of herbal medicines is safe, but actually when the herbal medicines is taken together with synthetic medicines, there are interaction potential that should be monitored. The purpose of this study was to analyze the Pharmacokinetic Interaction of Captopril Combination with Soursop Leaf Decoction.
This study was an advanced experimental study with a random block design. The group of test animals was divided into three groups, namely the captopril group, the combination group of captopril and soursop leaf decoction at the same time, and the combination group of captopril and soursop leaf decoction with an consumption interval of 2 hours.
The results of the descriptive analysis showed that there were differences in the pharmacokinetic profile of each group. Combination with captopril with soursop leaf decoction is able to increase captopril levels in blood plasma and increase the elimination rate of captopril. However, the statistical analysis showed there is no significant difference.
References
[2]. Riset Kesehatan Dasar (Riskesdas). 2018. Badan Penelitian Dan Pengembangan Kesehatan Kementerian RI Tahun 2018.
[3]. Paramita S, Dkk. 2017. Pola Penggunaan Obat Bahan Alam Sebagai Terapi Komplementer Pada Pasien Hipertensi Di Puskesmas. Jurnal Sains Dan Kesehatan. 2017. Vol 1. No 7. P-Issn: 2303-0267, E-Issn: 2407-6082. DOI: Https://Doi.Org/10.25026/Jsk.V1i7.56
[4]. Coria-Tellez Av, Montalvo-Gonzalez E, Yahia Em, Obledo-Vazquez En. (2016). Annona Muricata: A Comprehensive Review On Its Traditional Medicinal Uses, Phytochemicals, Pharmacological Activities, Mechanisms Of Action And Toxicity. Arabian Journal Of Chemistry. Http://Dx.Doi.Org/10.1016/J.Arabjc.2016.01.004.
[5]. Sukandar, E.Y, Sigit J.I, Dewi P.N. 2014. Uji Efek Penurunan Tekanan Darah Ekstrak Etanol Daun Sirsak (Annona Muricata L.) Pada Tikus Wistar Jantan. Acta Pharmaceutica Indonesia, Vol. Xxxix, No. 1 & 2
[6]. Patel S, Patel Jk. (2016). A Review On A Miracle Fruits Of Annona Muricata. Journal Of Pharmacognosy And Phytochemistry. 5(1): 137-148. E-ISSN: 2278-4136 P-ISSN: 2349-8234 JPP 2016; 5(1): 137-148
[7]. Safruddin, Alfira N. 2017. Efektivitas Daun Sirsak Terhadap Penurunan Tekanan Darah Pada Penderita Hipertensi Di Wilayah Kerja Puskesmas Balibo Kabupaten Bulukumba. Jurnal Kesehatan Panrita Husada | Vol. 2 No.2
[8]. Nurhanifah F. 2013. Perbandingan Pengaruh Daun Sirsak (Annona Muricata L) Terhadap Penurunan Tekanan Darah Pada Penderita Hipertensi Derajat 1 Dan Hipertensi Derajat 2 Di Wilayah Kerja Puskesmas Tanjung Pati Kabupaten Lima Puluh Kota Tahun 2013.
[9]. Jacob A. 2016. Efektifitas Pemberian Air Rebusan Daun Sirsak Terhadap Penurunan Tekanan Darah Pada Penderita Hipertensi Di Desa Motoling I.
[10]. Yulianto S. 2019. Pengetahuan Masyarakat Tentang Daun Sirsak Sebagai Antihipertensi. Jurnal Kebidanan Dan Kesehatan Tradisional, Volume 4, Ni,2, Halaman 57 – 119.
[11]. James, P. A., Suzanne, O.M.D., Barry, L.C., William, C.C., Cheryl, D.H., Joel, H., Et Al. 2013. 2014 Evidence-Based Guideline For The Management Of High Blood Pressure In Adults Report From The Panel Members Appointed To The Eighth Joint National Committee (Jnc 8). Jama (Journal Of American Medical Association). Doi: 10.1001/Jama.2013.284427
[12]. Chen YJ, Li LJ, Tang WL, Song JY, Qiu R, Li Q, Xue H, Wright JM. First-Line Drugs Inhibiting The Renin Angiotensin System Versus Other First-Line Antihypertensive Drug Classes For Hypertension. Cochrane Database Syst Rev. 2018 Nov 14;11:CD008170. Doi: 10.1002/14651858.CD008170.Pub3.
[13]. Liu Q.M.K. 2014. Pharmacokinetic Interactions Between Herbal Medicines And Prescribed Drugs: Focus On Drug Metabolic Enzymes And Transporters. Vurr Drug Metab. 15(8):791-807. Doi: 10.2174/1389200216666150223152348.
[14]. Mirawati. 2017. Interaksi Farmakokinetik Dan Farmakodinamik Ekstrak Kulit Buah Manggis (Garcinia Mangostana L) Dengan Gliklazid Dan Metformin Pada Tikus Model Diabetik. Disertasi.
[15]. Nwokocha Cr, Owu Du, Gordon A, Thaxter K, Mccalla G, Ozolua Ri, Young L. (2012). Possible Mechanisms Of Action Of The Hypotensive Effect Of Annona Muricata (Soursop) In Normotensive Sprague-Dawley Rats. Pharmaceutical Biology. 50(11): 1436-1441.
[16]. Chukwuemeka R Et Al. 2012. Possible Mechanism Of Action Of The Hypotensive Effect Of Annona Muricata (Soursop) In Normotensive Spragur-Dawley Rats. Pharmaceutical Biology, 2012; Early Online: 1–6. ISSN 1388-0209 Print/ISSN 1744-5116 Online. DOI: 10.3109/13880209.2012.684690
[17]. Moghadamtousi SZ Et Al. 2015. Annona Muricata (Annonaceae) : A Review Of Its Traditional Uses, Isolated Acetogenins And Biological Activities. Int. J. Mol. Sci. 2015, 16, 15625-15658; Doi:10.3390/Ijms160715625
[18]. Ana V Et Al. 2018. Annona Muricata : A Comprehensice Review On Its Traditional Medicinal Uses, Phytocemicals, Pharmacological Activities, Mechanisms Of Action And Toxicity. Arabian Journal Of Chemistry.
[19]. Sokpe A Et Al. 2020. Hypotensive And Antihypertensive Properties And Safety Fir Use Of Annona Muricata And Persea Americana And Their Combination Products. Evid Based Complement Alternat Med. 2020 Dec 10;2020:8833828. Doi: 10.1155/2020/8833828. Ecollection 2020.
[20]. Hamdan, Musniati N. 2020. Ekstrak Daun Sirsak Terhadap Tekanan Darha Pada Hipertensi. Journal Of Holistic And Traditional Medicine. Vol..05 No,02. E-ISSN.2541-5409, P-ISSN.2541-4178.
[21]. Swastini N. 2021. Literatur Review : Efketivitas Daun Sirsak (Annona Muricata Linn) Terhadap Penurunan Tekanan Darah Pada Hipertensi. Jurnal Imiah Kesehatan Sandi Husada. Volume 10| Nomor 2| Desember|2021 E-ISSN: 2654-4563 Dan P-ISSN: 2354-6093. DOI 10.35816/Jiskh.V10i2.618
[22]. Perhimpunan Dokter Hipertensi Indonesia. 2019. Konsensus Penatalaksanaan Hipertensi 2019.
